In the reflection paper the European Medicines Agency (EMA) provides an overview of the contemporary outlook on the use of AI to “support the safe and effective development, regulation and use” of medicines.

NATO published an AI-strategy including several principles and other points of attention.

Subsequent to several declarations of principes, the Chinese governement published a first set of ethical principles relating to AI.